News

Health on MSN23h
Zepbound or Wegovy? Head-to-Head Trial Says One Is Better for Weight Loss
Eli Lilly’s Zepbound proved more effective than Novo Nordisk’s Wegovy in a new head-to-head trial, though both medications ...
Why Some People Are Microdosing Popular Weight-Loss Drugs
Microdosing isn’t just popular for psychedelics. Some consumers are taking smaller than standard doses of GLP-1s—the popular ...
Weight-loss drugs may lower cancer risk in people with diabetes, a study suggests
Researchers are beginning to wonder if blockbuster drugs like Wegovy, Ozempic and Zepbound could play a role in preventing ...
Novo slips in obesity-med fight
Novo's Wegovy has lost market share to Eli Lilly's Zepbound, and a new head-to-head study found that Zepbound patients lost ...
Zacks Investment Research on MSN23h
CI's Unit Unveils Offering to Expand Access to GLP-1 Medications
The health services arm of The Cigna Group CI, Evernorth, recently introduced a pharmacy benefit offering designed to enhance ...